As of Apr 28
| +0.02 / +1.80%|
The 1 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +430.97% increase from the last price of 1.13.
The current consensus among 1 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.